Multilesional pyoderma gangrenosum is associated with longer healing times and higher rates of underlying comorbidities: A single-center prospective registry study
Saved in:
Main Authors: | Hannah Zhao, BA (Author), Arash Mostaghimi, MD, MPA, MPH (Author), Jonathan M. Sisley, BS (Author), Alex G. Ortega-Loayza, MD, MCR (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modified dose of guselkumab for treatment of pyoderma gangrenosum
by: Ashley M. Reese, BS, et al.
Published: (2022) -
Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs
by: Becker SL, et al.
Published: (2023) -
Progression of pyoderma gangrenosum with angioinvasive fungus
by: Delice Kayishunge, BS, et al.
Published: (2021) -
Treatment of pyoderma gangrenosum with apremilast monotherapy
by: Zachary A. Bordeaux, BS, et al.
Published: (2022) -
The effect of comorbid autoimmune gastrointestinal diseases on time to resolution of pyoderma gangrenosum: A retrospective review
by: Hugh Nymeyer, MD, PhD, et al.
Published: (2023)